Fearless Ventures
Venture Capital
Active
San Francisco, United States
4
70M
2
1.00
0.50
- Stages of investment
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4 participants. Despite the Fearless Ventures, startups are often financed by M Ventures, Jazz Venture Partners, Canepa Healthcare. The meaningful sponsors for the fund in investment in the same round are Omidyar Technology Ventures, DG Incubation, CLSA.
Among the various public portfolio startups of the fund, we may underline Akili Interactive Labs Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care.
The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
Investor highlights
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 25800000
- Fund raised date
- 2018-08-20
Analytics
- Total investments
- 4
- Lead investments
- 0
- Rounds per year
- 1.00
- Follow on index
- 0.50
- Investments by industry
- Health Care (4)
- Therapeutics (4)
- Biotechnology (4)
- Medical (2)
- Medical Device (2) Show 2 more
- Investments by region
-
- Germany (2)
- United States (2)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 900M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Akili Interactive Labs | 09 Aug 2018 | Biotechnology, Health Care, Medical Device, Medical, Neuroscience, Therapeutics | Late Stage Venture | 13M | United States, Boston, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.